Nvidia Isn't the Only Company Getting Rich From the AI Boom

Credo Technology reported fiscal Q1 2027 revenue of $479 million, up 114.7% year over year and above the $470.38 million consensus, while non-GAAP EPS of $1.20 also beat estimates. Management expects full-year revenue growth above 85% and optical revenue above $600 million; the article’s 12-month price target is $263.13, implying 20.35% upside from its $218.64 reference price. Customer concentration is a key risk: the two largest customers represented 33% and 28% of quarterly revenue, respectively, and GAAP gross margin declined to 64.5% from 68.2%.

Analysis

The investable question is not whether AI clusters need more connectivity, but whether Credo can convert a small number of hyperscaler programs into durable, diversified revenue before customer bargaining power or competing architectures compress returns. With two customers representing 61% of quarterly revenue, a single order pause could overwhelm otherwise strong category growth; inventory accumulation makes that downside potentially sharper if deployments slip. The optical roadmap is an upside option, not yet proof of recurring demand: verify realized optical revenue, customer breadth, and inventory turns rather than underwriting management’s product-level expectations.

Relative valuation comparisons are weak evidence of mispricing on their own. Credo, Astera Labs (ALAB), and Marvell (MRVL) have different product mixes and risk profiles; a lower multiple may partly price Credo’s concentration and execution risk. The promotional article’s high-confidence target should not be treated as independent validation. NVIDIA (NVDA) benefits from cluster expansion, but connectivity suppliers also face second-order substitution: faster optical adoption can expand Credo’s opportunity while displacing electrical solutions, and platform design choices can shift content among vendors.

Near term, the sharp recovery argues against chasing. Over 1–3 months, watch Marvell’s October 6 Investor Day commentary and Credo’s next evidence on optical ramp, customer orders, and gross-margin direction. Over 6–18 months, successful optical deployments and customer diversification could support multiple expansion; delayed AI capex, customer insourcing, or a shift in architecture could reverse it.

Key Decisions for Investors

• Do not buy CRDO solely on the article’s target or peer-multiple gap. Consider a staged long only on a pullback or after confirmation that optical revenue is ramping and customer concentration is easing; size below a typical growth holding given the order-cliff risk.
• Set an explicit thesis check for the next earnings reports: optical revenue trajectory, customer concentration, inventory relative to sales, and gross-margin trend. A major customer order reduction or inventory rising faster than revenue would invalidate the near-term long case.
• Treat ALAB and MRVL as exposure alternatives, not automatic hedges: compare product-level growth, customer mix, and valuation using current filings and guidance before establishing a relative-value trade. Marvell’s Investor Day is a near-term information catalyst, not by itself a CRDO sell signal.
• Avoid adding after the recent rebound absent new operating evidence. If confirmed optical adoption and broader customer wins arrive while CRDO underperforms connectivity peers, revisit a long position; if guidance weakens or customer concentration worsens, stand aside rather than average down.